Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules.
暂无分享,去创建一个
M F del Guercio | R W Chesnut | A Sette | J Sidney | J. Sidney | H. Grey | A. Sette | R. Chesnut | E. Celis | M. del Guercio | S. Southwood | R. Kubo | S Southwood | H M Grey | R T Kubo | E Celis | P A Wentworth | P. Wentworth | E. Celis
[1] J. Rothbard,et al. Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces. , 1990, International immunology.
[2] M. Aidoo,et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria , 1992, Nature.
[3] R W Chesnut,et al. Characterization of the specificity of peptide binding to four DR haplotypes. , 1990, Journal of immunology.
[4] S. Rowland-Jones,et al. A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides , 1993, European journal of immunology.
[5] P Parham,et al. Evolution of class-I MHC genes and proteins: from natural selection to thymic selection. , 1990, Annual review of immunology.
[6] William S. Lane,et al. Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle , 1992, Nature.
[7] K. Parker,et al. Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[8] P Parham,et al. Structure, function, and diversity of class I major histocompatibility complex molecules. , 1990, Annual review of biochemistry.
[9] H. Rammensee,et al. Peptide motifs of closely related HLA class I molecules encompass substantial differences , 1992, European journal of immunology.
[10] A. Townsend,et al. Antigen recognition by class I-restricted T lymphocytes. , 1989, Annual review of immunology.
[11] D. Wiley,et al. The antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2 , 1993, Cell.
[12] H. Grey,et al. In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides. , 1995, Molecular immunology.
[13] D. R. Madden,et al. Identification of self peptides bound to purified HLA-B27 , 1991, Nature.
[14] W R Mayr,et al. Nomenclature for factors of the HLA system, 1995. , 1995, Tissue antigens.
[15] G. Klein,et al. An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[16] B. Malissen,et al. Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies. , 2008, Tissue antigens.
[17] P. Stastny,et al. DNA typing for HLA class I alleles: I. Subsets of HLA-A2 and of -A28. , 1992, Human immunology.
[18] R. Tampé,et al. A sequential model for peptide binding and transport by the transporters associated with antigen processing. , 1994, Immunity.
[19] R. Zinkernagel,et al. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system , 1974, Nature.
[20] P. Parham,et al. Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes , 1995, Current Biology.
[21] H. Ploegh,et al. Substrate specificity of allelic variants of the TAP peptide transporter. , 1994, Immunity.
[22] A. Vitiello,et al. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans. , 1995, The Journal of clinical investigation.
[23] C. Barnstable,et al. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis , 1978, Cell.
[24] A Sette,et al. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. , 1994, Journal of immunology.
[25] T. Elliott,et al. Peptide selection by class I molecules of the major histocompatibility complex , 1993, Current Biology.
[26] P. Cresswell,et al. Human transporters associated with antigen processing possess a promiscuous peptide-binding site. , 1994, Immunity.
[27] P. Cresswell,et al. Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[28] J. Sidney,et al. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. , 1994, Molecular immunology.
[29] D. Wiley,et al. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. , 1991, Journal of molecular biology.
[30] O. Rötzschke,et al. Consensus motifs and peptide ligands of MHC class I molecules. , 1993, Seminars in immunology.
[31] B. Guy,et al. Six epitopes reacting with human cytotoxic CD8+ T cells in the central region of the HIV-1 NEF protein. , 1991, Journal of immunology.
[32] J. Neefjes,et al. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. , 1993, Science.
[33] M F del Guercio,et al. Several HLA alleles share overlapping peptide specificities. , 1995, Journal of immunology.
[34] K. Parker,et al. Endogenous peptides with distinct amino acid anchor residue motifs bind to HLA-A1 and HLA-B8. , 1994, Journal of immunology.
[35] F. Greenwood,et al. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. , 1963, The Biochemical journal.
[36] B. Moss,et al. Mapping the fine specificity of a cytolytic T cell response to HIV-1 nef protein. , 1990, Journal of immunology.
[37] N. Suciu-Foca,et al. Naturally processed HLA class I bound peptides from c-myc-transfected cells reveal allele-specific motifs. , 1993, Journal of immunology.
[38] J. Sidney,et al. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules , 1993, Cell.
[39] Hans-Georg Rammensee,et al. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells , 1990, Nature.
[40] G Hermanson,et al. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. , 1995, Journal of immunology.
[41] R. Tosi,et al. HLA-A2-binding peptides cross-react not only within the A2 subgroup but also with other HLA-A-locus allelic products. , 1994, Human immunology.
[42] Antonio Lanzavecchia,et al. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells , 1989, European journal of immunology.
[43] H. Rammensee,et al. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.
[44] P. Terasaki,et al. The HLA Complex , 1985 .
[45] C. Bordignon,et al. Characterization of natural peptide ligands for HLA-B*4402 and -B*4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA-B44 heavy chain. , 1994, Tissue antigens.
[46] R. Henderson,et al. Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling. , 1993, Journal of immunology.
[47] K. Tadokoro,et al. Sequences of four splits of HLA-A10 group. Implications for serologic cross-reactivities and their evolution. , 1994, Human immunology.
[48] M. Lotze,et al. Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes. , 1993, Journal of immunology.
[49] V. Engelhard. Structure of peptides associated with MHC class I molecules. , 1994, Current opinion in immunology.
[50] A Sette,et al. Definition of specific peptide motifs for four major HLA-A alleles. , 1994, Journal of immunology.
[51] R M Zinkernagel,et al. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. , 1979, Advances in immunology.
[52] E. Adams,et al. The Origins of HLA‐A,B,C Polymorphism , 1995, Immunological reviews.
[53] J. Trapani,et al. Molecular analysis of the serologically defined HLA-Aw19 antigens. A genetically distinct family of HLA-A antigens comprising A29, A31, A32, and Aw33, but probably not A30. , 1989, Journal of immunology.
[54] J. Neefjes,et al. Peptide selection by MHC-encoded TAP transporters. , 1994, Current opinion in immunology.
[55] P. Terasaki,et al. HLA and Disease Associations , 1985, Springer New York.
[56] F. Chisari,et al. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis , 1993, The Journal of experimental medicine.
[57] Arne Svejgaard,et al. Nomenclature for Factors of the HLA System, 1995 , 1995, Vox sanguinis.
[58] K. Parker,et al. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs. , 1993, Journal of immunology.